Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
Open Access
- 1 September 2017
- journal article
- review article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 32 (5), 769-779
- https://doi.org/10.3904/kjim.2016.391
Abstract
The introduction of drug-eluting stents (DES) in the practice of percutaneous coronary intervention (PCI) has substantially reduced angiographic and clinical restenosis but is associated with an increasing propensity for very late stent thrombosis (ST). Among several clinical, lesion, or procedure-related predictors of ST, early discontinuation of dual antiplatelet therapy (DAPT) is the most important factor for DES-associated late thrombosis; therefore, the optimal duration of DAPT is a major issue to be critically considered in the current DES era. Given that the benefit and risk of longer duration DAPT should be simultaneously considered, the optimal DAPT period following DES implantation has been controversial. Several small-to-medium sized randomized clinical trials and observational registries have indicated that short-term DAPT (< 6 months) is not inferior to 12-month DAPT with fewer bleeding events, whereas prolonged duration of DAPT (> 12 months) failed to prove its superiority. However, compelling evidence from a landmark DAPT trial has clearly demonstrated the efficacy of prolonged DAPT up to 30 months in terms of preventing ST and major cardiovascular adverse events at the expense of major bleeding. In addition, coupled with various risk algorithms, a more individualized approach to balance the efficacy and safety of optimal DAPT duration has been emphasized. In this review article, we systematically summarize the cumulative evidence from key clinical studies and try to help the physician make decisions on the optimal duration of DAPT in contemporary PCI practice.Keywords
This publication has 65 references indexed in Scilit:
- 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Journal of Cardio-Thoracic Surgery, 2014
- Drug-Eluting Coronary-Artery StentsThe New England Journal of Medicine, 2013
- Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent ThrombosisJACC: Cardiovascular Interventions, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive SummaryJournal of the American College of Cardiology, 2011
- Stent ThrombosisJournal of Invasive Cardiology, 2010
- Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year periodEuropean Heart Journal, 2009
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction PatientsJournal of the American College of Cardiology, 2008
- Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 2007
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisJournal of the American College of Cardiology, 2007
- Incomplete Neointimal Coverage of Sirolimus-Eluting Stents: Angioscopic FindingsJournal of Invasive Cardiology, 2006